Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Primary Breast Cancer × Carboplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 656 Lung Neoplasms 282 Ovarian Neoplasms 279 Breast Neoplasms 225 Fallopian Tube Neoplasms 136 Neoplasms 118 Small Cell Lung Carcinoma 117 Triple Negative Breast Neoplasms 114 Squamous Cell Carcinoma of Head and Neck 102 Carcinoma, Ovarian Epithelial 100 Neoplasm Metastasis 72 Head and Neck Neoplasms 66 Endometrial Neoplasms 63 Uterine Cervical Neoplasms 58 Adenocarcinoma of Lung 58 Esophageal Neoplasms 55 Brain Neoplasms 45 Central Nervous System Neoplasms 44 Recurrence 42 Prostatic Neoplasms 40 Lymphoma, Large B-Cell, Diffuse 39 Carcinoma 39 Neuroblastoma 38 Parkinson Disease 4, Autosomal Dominant Lewy Body 37 Urinary Bladder Neoplasms 36 Lymphoma 33 Esophageal Squamous Cell Carcinoma 33 Carcinoma, Squamous Cell 30 Melanoma 28 Stomach Neoplasms 27

Interventions

Docetaxel 4 Epirubicin 3 Cyclophosphamide 3 Vinorelbine 1 Tamoxifen 1 Paclitaxel 1 Iodine-123 1 Fluorouracil 1 Doxorubicin 1 Carboplatin 1 CP protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00527449 2010-01-15

ETCat01

Klinikum Weissenfels

Phase 2 Completed

Primary Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡